Replies to post #3015 on Galectin Therapeutics Inc. (GALT)

[biotech2010]

You specifically said that 'maybe they are getting closer to a deal with a big pharma'

Something the CEO said isn't happening because they aren't speaking about partnerships with U.S. and multinational companies. He said that during the last conference call, it is public record.

The stock has gone higher but the truth is that they aren't pursuing a partnership with a big pharma unless the CEO lied during the conference call.

You are entitled to think whatever you want but the facts don't lie regardless of how anyone tries to spin them.

I own shares in GALT, I hope the price goes to $100 although it's impossible without both a successful CX trial and a new CEO because the current one has no clue about how to build a company.

[Chess Master]

Look I dont want to defend his negativity but he has a right to his opinion. What I do want to say counter to his grossly mistaken argument about management is that GALT is undervalued. GALT could be run by an incompetent politician and if so you would apply a discount to the price but what is the true market cap of this company. $84 million? NO WAY. It should be more like 500 mil to 2.0 bil RIGHT NOW! So how many hundreds of millions of discount should you apply because Traber is at the helm? Apply them and you still see that GALT is ridiculously undervalued for the stage of development that they are at. The stock should be $10 min. People are starting to see that so dont expect this rise to take a breather until then.